ETF Research Center

The ROBO Global Healthcare Technology and Innovation ETF tracks a market-cap selected and weighted index of global healthcare technology companies.

FUND BASICS
Category	Global Equities
Fund Sponsor	Exchange Traded Concepts
Website	roboglobaletfs.com
Inception date	Jun 25, 2019
Assets (mns)	$10
Currency	USD
Expense ratio	68 bp
Distributions	Annually

FUND STRUCTURE
Regulation	Open-Ended Fund
Custodian
Weighting	Market Cap
Index replication
Uses derivatives	No
Options available	No

SECTOR BREAKDOWN

CONSTITUENT BREAKDOWN
No. of constituents	86
Wgt avg mkt cap (mns)	$23,156
Large cap (>$10bn)	40.6%
Mid cap ($2-10bn)	30.9%
Small cap (<$2bn)	26.8%
Developed mkts	100.0%
Emerging mkts	0.0%

TOP TEN HOLDINGS
Total	16.8 %
TABULA RASA HEALTHCARE, INC.	2.1 %
TELADOC INC	1.9 %
PING AN HEALTHCARE AND TECHNOLOGY	1.9 %
DEXCOM INC	1.7 %
VOCERA COMMUNICATIONS INC	1.6 %
CHARLES RIVER LABORATORIES	1.6 %
IRHYTHM TECHNOLOGIES, INC.	1.6 %
NEOGENOMICS INC	1.5 %
PENUMBRA, INC.	1.5 %
LONZA GROUP AG-REG	1.5 %

TOP COUNTRY EXPOSURE
	UNITED STATES	78.3 %
	SWITZERLAND	4.6 %
	BRITAIN	2.6 %
	NETHERLANDS	2.4 %
	CHINA	1.9 %
	JAPAN	1.3 %
	GERMANY	1.2 %
	ITALY	1.2 %
	AUSTRALIA	1.2 %
	BELGIUM	1.1 %

HISTORICAL PERFORMANCE info

	Custom date range	Compare to
	thru

Standardized Annual Returns (thru January 01)
Year-to-date	1 year	5 years	10 years	Since Incep.
--	--	--	--	0.0%

Market Correlations
versus...	Beta	R-squared
S&P500	--	--
MSCI EAFE	--	--
MSCI Emg. Mkts.	--	--

Technical Indicators
Recent close	$27.33
30d moving avg.	$27.66
Annualized volatility	0.0%
Short interest (ETF)	1.2%
Relative strength (RSI)	60

Liquidity measures
Avg. volume (thou.)	7
Turnover	2.0%
Bid/Ask (% of price)	0.14%
ADV underlying (mns)	$9,694

Distributions

FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the ROBO Global Healthcare Technology & Innovation ETF ETF based on the alternatives' overlap in portfolio holdings with HTEC. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker:

HTEC

Expense:

68 bp

ALTAR Score™:

0.0%

ALTERNATIVE ETFs BASED ON OVERLAP WITH HTEC
Ticker	Fund Name	Overlap¹ vs HTEC (%)	Expense ratio (bp)	Savings vs HTEC (bp)	ALTAR Score™ (%)	ALTAR vs HTEC (%)
XHE	SPDR S&P Health Care Equipment ETF	33.7	35	33	2.2	+2.2
FXH	First Trust Health Care AlphaDEX Fund	24.5	62	6	5.5	+5.5
RYH	Invesco S&P 500 Equal Weight Health Care ETF	24.2	40	28	6.8	+6.8
JHMH	John Hancock Multifactor Healthcare ETF	24.2	40	28	6.5	+6.5
GDNA	Goldman Sachs Motif Human Evolution ETF	23.8	50	18	1.0	+1.0
VHT	Vanguard Health Care Index Fund	21.9	10	58	5.7	+5.7
FHLC	Fidelity MSCI Health Care Index ETF	21.7	8	60	5.8	+5.8
IHI	iShares U.S. Medical Devices ETF	21.4	43	25	3.7	+3.7
IYH	iShares U.S. Healthcare ETF	20.6	43	25	6.3	+6.3
IEHS	iShares Evolved U.S. Healthcare Staples ETF	20.0	18	50	5.8	+5.8
IXJ	iShares Global Healthcare ETF	20.0	46	22	6.4	+6.3
LNGR	Global X Longevity Thematic ETF	19.0	50	18	3.4	+3.4
XLV	Health Care Select Sector SPDR Fund	17.8	13	55	7.2	+7.2
PTH	Invesco DWA Healthcare Momentum ETF	17.7	60	8	-3.3	-3.3
ROBO	Robo Global Robotics & Automation Index ETF	14.5	95	-27	3.6	+3.6
GNOM	Global X Genomics & Biotechnology ETF	13.9	68	0	-4.5	-4.5
BTEC	Principal Healthcare Innovators Index ETF	13.2	42	26	-4.1	-4.1
PSCH	Invesco S&P SmallCap Health Care ETF	12.5	29	39	3.3	+3.3
BBH	VanEck Vectors Biotech ETF	12.1	35	33	4.1	+4.1
FBT	First Trust NYSE Arca Biotechnology Index Fund	12.1	57	11	-0.1	-0.1

¹Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

	2015	2016	2017	2018	2019	2020E	2021E
Sales per share	**	**	**	**	**	**	**
Earnings per share	**	**	**	**	**	**	**
Dividends per share	**	**	**	**	**	**	**
Book value per share	**	**	**	**	**	**	**

Sales per share growth		**%	**%	**%	**%	**%	**%
EPS growth		**%	**%	**%	**%	**%	**%

Sales per share growth		**%	**%	**%	**%	**%	**%
EPS growth		**%	**%	**%	**%	**%	**%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est.	**%		Debt-to-equity	**x
Asset turnover	**%		Assets-to-equity	**x

Return on equity

Revision activity*

*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS

	2019	2020E	2021E
Price-to-sales	**	**	**
Price-to-earnings	**	**	**
Price-to-cash flow	**	**	**
Price-to-growth	**	**	**
Price-to-book value	**	**	**
Yield	**	**	**

Historical valuation trends

Forward multiple:	ROBO Global Healthcare Technology & Innovation ETF
Relative to:	S&P500	MSCI EAFE	MSCI Emg. Mkts.	Other ETF:

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant.

ALTAR Score™

Calculation of ALTAR Score™
Avg. Return on Equity	3.6	%
Divided by: Fwd. P/BV	5.2	x
Less: Expense ratio	68	bp
Equals: ALTAR Score	0.0	%

More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS

COMPOSITE RATING	1.40	CATEGORY AVERAGE	1.55

The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale: BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3. Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.